Navigation Links
Pre-pregnancy diabetes increases risk of MRSA among new mothers
Date:7/1/2013

Washington, DC, July 1, 2013 Pregnant women with diabetes are more than three times as likely as mothers without diabetes to become infected with methicillin-resistant Staphylococcus aureus (MRSA) before hospital discharge, according to a study in the July issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

The study aim was to investigate the extent to which pre-pregnancy and gestational diabetes are associated with MRSA infection. Researchers found that pre-pregnancy diabetes was associated with increased risk of MRSA following delivery, but found no association between MRSA and gestational diabetes.

Researchers from the University of California, Los Angeles analyzed more than 3.5 million delivery-related hospital admissions from the Nationwide Inpatient Sample (NIS), a system that accounts for 20 percent of community hospitals in the United States. Of these admissions, 5.3 percent of mothers (185,514 women) acquired diabetes during their pregnancy (gestational diabetes) and nearly one percent (28,939) had pre-pregnancy diabetes. The researchers identified 563 cases of invasive MRSA among the mothers following delivery. To the extent that infection site information was available, the most frequent sources of infection were skin (30.9 percent), urinary tract (6.4 percent), other genitourinary sites (5.2 percent), wound infections (3.0 percent) and septicemia (2.0 percent).

"When combined with previous research showing increased risk of certain infections in diabetic persons, it seems likely that diabetic women are at increased risk of MRSA infection compared with other women admitted for delivery of an infant," conclude the authors. "As we wait for further research on this topic, it might seem prudent for hospitals to be vigilant about possible MRSA risk among diabetic women in labor and delivery."

MRS
'/>"/>

Contact: Liz Garman
egarman@apic.org
202-454-2604
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mothers Pre-Pregnancy Weight Tied to Kids IQ, Study Says
2. Study shows link between pre-pregnancy obesity and lower test scores
3. UCI researchers awarded $2.27 million to create novel diabetes treatments
4. Huge falls in diabetes mortality in UK and Canada since mid-1990s
5. RSNA: Exercise Benefits Patients with Type 2 Diabetes
6. Exercise benefits patients with type 2 diabetes
7. New analysis shows that patients with Type 2 diabetes and mild renal impairment had similar improvement in blood sugar control and experienced less hypoglycemia with JANUVIA (sitagliptin) compared to sulfonylurea
8. Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease
9. Loyola receives $1.5 million grant to study vitamin D for diabetes and depression
10. NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes
11. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin), KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone) Now Available in Pharmacies in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Salt Lake City, UT (PRWEB) , ... August 03, 2015 , ... ... announced the release of the T500 cable , a Bluetooth Code Reader accessory ... mobile devices, including iOS products. The T500 helps enable a variety of barcode ...
(Date:8/3/2015)... ... August 03, 2015 , ... They know every second counts. And when it ... offers some of the best care in the nation. For the past two months, ... average blood clot removal time in the country. During the months of June and ...
(Date:8/3/2015)... PA (PRWEB) , ... August 03, 2015 , ... ... Africa , Infectious diseases researchers from the University of Pittsburgh School of Medicine ... rollout of HIV prevention drugs in sub-Saharan Africa. , A cooperative agreement ...
(Date:8/3/2015)... ... 2015 , ... Catalent Pharma Solutions, the leading global provider ... products, today welcomed the announcement by OPKO Health that the US Food and ... treatment for chronic kidney disease (CKD) and vitamin D insufficiency, which uses Catalent’s ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... of its industry-defining contract lifecycle management solution, as well as announced the date ... increase the speed and ease of contract management tasks as well as enhancements ...
Breaking Medicine News(10 mins):Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Novatus Unveils Milestone Software Release 2
... published in an upcoming issue of the World Health Organisation ... sensitive issue of border control, and the need for coherent ... flu pandemic . The report comes after the recent ... A (HN51) in Northern Sumatra: although the outbreak was contained ...
... Pharma US, Inc. today,announced results of an ... a prompt and sustained (over the 4-day,treatment ... among,hospitalized patients with euvolemic and hypervolemic hyponatremia ... correction. The study results were presented,during the ...
... All Iowa ... Communities, ... the Iowa State Police Association, the Partnership for a,Drug-Free America, along ... outreach program designed to,raise awareness and reduce demand for the highly ...
... pressure, damages cells , WEDNESDAY, Oct. 10 (HealthDay News) ... kidney disease in rats by raising their blood pressure ... report. , Previous studies in workers have found an ... (hardening of the arteries), kidney disease and gout. , ...
... smooth muscle tumors (SMTs, including leiomyoma and leiomyosarcoma) ... originate from a muscular layer of the gastrointestinal ... stomach, small intestine, and colon. SMTs are difficult ... and complete surgical resection is still considered to ...
... Vaccine Congress: A first-in-man trial of a live Listeria ... News). The Phase I/II trial was testing Lovaxin C ... developed by Advaxis as an immunotherapy that is intended ... papilloma virus (HPV), including cervical cancer and head and ...
Cached Medicine News:Health News:Report highlights inadequate pandemic planning as a threat to EU security 2Health News:Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia 2Health News:Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia 3Health News:Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia 4Health News:Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia 5Health News:Partnership for a Drug-Free America and Council Bluffs Police Department Introduce Methamphetamine Prevention Program to Iowa Law Enforcement 2Health News:Partnership for a Drug-Free America and Council Bluffs Police Department Introduce Methamphetamine Prevention Program to Iowa Law Enforcement 3Health News:Advaxis, Inc. phase I/II results of lovaxin C in cervical cancer study released 2
(Date:8/3/2015)... 2015  BioElectronics Corporation (OTC Pink: BIEL), maker of ... Andrew J. Whelan , President will be interviewed ... Business" at 9am EDT on Wednesday, August 5 th ... http://tunein.com/radio/Money-Matters-Boston-1120-s27548/ Mr. ... the company,s flagship product, ActiPatch Therapy, is achieving in ...
(Date:8/3/2015)... BOULDER, Colo., Aug. 3, 2015  Array BioPharma ... for the fourth quarter and full year of ... Ron Squarer, Chief Executive Officer of Array, noted, ... Phase 3, are on track for regulatory submissions ... in BRAF-mutant melanoma and BRAF-mutant colorectal cancer further ...
(Date:8/3/2015)... Aug. 3, 2015  Celsion Corporation (NASDAQ: ... host a conference call to discuss its second ... on its development programs for ThermoDox®, its proprietary ... acquired technology platforms, TheraPlas™ and TheraSilence™, in immunotherapy ... Monday, August 10, 2015. To participate in the ...
Breaking Medicine Technology:UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2
... Medical Imaging of Fredericksburg is one of ...  Best of 2011 Radiology Facilities issue, a ... In an article titled "Small Town ... Imaging of Fredericksburg, a partnership between Mary Washington ...
... Inc., a biotechnology company developing orally-available antiviral therapeutics, ... for CMX001 in a late-breaker presentation at the ... Chemotherapy (ICAAC, Chicago – September 17-20).   ... Diseases Service at Memorial Sloan-Kettering Cancer Center and ...
Cached Medicine Technology:Medical Imaging of Fredericksburg Highlighted in Imaging Economics' Best of 2011 Radiology Facilities Issue 2Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 2Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 3